Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
November 9, 2005
Dipeptide-based highly potent doxorubicin antibody conjugates
Scott C Jeffrey, Minh T Nguyen, Jamie B Andreyka, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 6, 2009
The pharmacologic basis for antibody-auristatin conjugate activity
Stephen C Alley, Xinqun Zhang, Nicole M Okeley, et al.
Bioconjugate Chemistry
|
September 21, 2013
Metabolic engineering of monoclonal antibody carbohydrates for antibody-drug conjugation
Nicole M Okeley, Brian E Toki, Xinqun Zhang, et al.
Angewandte Chemie (International Ed. in English)
|
December 15, 2016
Orthogonal Cysteine Protection Enables Homogeneous Multi-Drug Antibody-Drug Conjugates
Matthew R Levengood, Xinqun Zhang, Joshua H Hunter, et al.
Molecular Pharmaceutics
|
August 2, 2018
Lactone Stabilization is Not a Necessary Feature for Antibody Conjugates of Camptothecins
Uland Y Lau, Lauren T Benoit, Nicole S Stevens, et al.
Bioconjugate Chemistry
|
March 5, 2008
Contribution of linker stability to the activities of anticancer immunoconjugates
Stephen C Alley, Dennis R Benjamin, Scott C Jeffrey, et al.
Bioconjugate Chemistry
|
September 18, 2003
Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates
Craig Beeson, James E Butrynski, Michael J Hart, et al.
Bioconjugate Chemistry
|
September 23, 2008
Novel peptide linkers for highly potent antibody-auristatin conjugate
Svetlana O Doronina, Tim D Bovee, David W Meyer, et al.
Bioconjugate Chemistry
|
September 18, 2003
Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineering
Charlotte F McDonagh, Kevin S Beam, Gabrielle J S Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2006
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen
Dangshe Ma, Christine E Hopf, Andrew D Malewicz, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Bioorganic & Medicinal Chemistry Letters
|
November 9, 2005
Dipeptide-based highly potent doxorubicin antibody conjugates
Scott C Jeffrey, Minh T Nguyen, Jamie B Andreyka, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 6, 2009
The pharmacologic basis for antibody-auristatin conjugate activity
Stephen C Alley, Xinqun Zhang, Nicole M Okeley, et al.
Bioconjugate Chemistry
|
September 21, 2013
Metabolic engineering of monoclonal antibody carbohydrates for antibody-drug conjugation
Nicole M Okeley, Brian E Toki, Xinqun Zhang, et al.
Angewandte Chemie (International Ed. in English)
|
December 15, 2016
Orthogonal Cysteine Protection Enables Homogeneous Multi-Drug Antibody-Drug Conjugates
Matthew R Levengood, Xinqun Zhang, Joshua H Hunter, et al.
Molecular Pharmaceutics
|
August 2, 2018
Lactone Stabilization is Not a Necessary Feature for Antibody Conjugates of Camptothecins
Uland Y Lau, Lauren T Benoit, Nicole S Stevens, et al.
Bioconjugate Chemistry
|
March 5, 2008
Contribution of linker stability to the activities of anticancer immunoconjugates
Stephen C Alley, Dennis R Benjamin, Scott C Jeffrey, et al.
Bioconjugate Chemistry
|
September 18, 2003
Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates
Craig Beeson, James E Butrynski, Michael J Hart, et al.
Bioconjugate Chemistry
|
September 23, 2008
Novel peptide linkers for highly potent antibody-auristatin conjugate
Svetlana O Doronina, Tim D Bovee, David W Meyer, et al.
Bioconjugate Chemistry
|
September 18, 2003
Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineering
Charlotte F McDonagh, Kevin S Beam, Gabrielle J S Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 28, 2006
Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen
Dangshe Ma, Christine E Hopf, Andrew D Malewicz, et al.
Page
of 9